Abeona Therapeutics (ABEO) Total Current Liabilities (2010 - 2026)

Abeona Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $31.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 72.64% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $31.0 million (up 72.64% YoY), while the FY2025 annual figure was $29.6 million, up 78.27% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $31.0 million, up from $29.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $34.5 million in Q2 2025, with the low at $7.4 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $13.7 million (2022), against an average of $16.7 million.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities sank 69.79% in 2022, then soared 119.0% in 2024.
• Abeona Therapeutics' Total Current Liabilities stood at $7.8 million in 2022, then soared by 72.54% to $13.4 million in 2023, then grew by 23.58% to $16.6 million in 2024, then jumped by 78.27% to $29.6 million in 2025, then climbed by 4.99% to $31.0 million in 2026.
• Business Quant data shows ABEO's Total Current Liabilities at $31.0 million in Q1 2026, $29.6 million in Q4 2025, and $22.2 million in Q3 2025.